Your browser doesn't support javascript.
loading
PLAG1-rearrangment in a uterine leiomyosarcoma with myxoid stroma and heterologous differentiation.
Thiryayi, Sakinah A; Turashvili, Gulisa; Latta, Eleanor K; Swanson, David; Zhang, Lei; Antonescu, Cristina R; Dickson, Brendan C.
Afiliação
  • Thiryayi SA; Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Turashvili G; Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Latta EK; Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Swanson D; Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Zhang L; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Dickson BC; Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
Genes Chromosomes Cancer ; 60(10): 713-717, 2021 10.
Article em En | MEDLINE | ID: mdl-34184333
ABSTRACT
A variety of molecular alterations have been reported in uterine leiomyosarcomas, but most are considered nondiagnostic. There are, however, rare exceptions including PLAG1 rearrangement which has recently been identified in a subset of myxoid leiomyosarcomas. A 41-year-old woman presented with symptoms of a fibroid. She underwent a myomectomy which revealed a high-grade uterine sarcoma with areas of myxoid stroma and heterologous elements. The tumor expressed desmin, smooth muscle actin, H-caldesmon, and estrogen and progesterone receptors. RNA sequencing revealed a novel TRIM13-PLAG1 fusion gene which was subsequently independently confirmed by fluorescence in situ hybridization. On further evaluation the patient was found to have multiple pulmonary metastases and died due to disease progression shortly after diagnosis. This report describes a novel fusion partner of PLAG1 in a uterine leiomyosarcoma with myxoid leiomyosarcoma and heterologous elements, thereby broadening the spectrum of morphologic and genetic findings within this rare group of neoplasms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Rearranjo Gênico / Diferenciação Celular / Células Estromais / Lipossarcoma Mixoide / Proteínas de Ligação a DNA / Leiomiossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Rearranjo Gênico / Diferenciação Celular / Células Estromais / Lipossarcoma Mixoide / Proteínas de Ligação a DNA / Leiomiossarcoma Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Genes Chromosomes Cancer Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá